TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENTX

Entera Bio Ltd

Healthcare · Biotechnology

2.70$ -2.0% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Entera Bio Ltd (ENTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.1% of the shares are freely tradable; institutional investors hold 34.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 34.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 173Mio.

Largest Shareholders

Institutions

Institutions ENTX
Name Stake (%) Shares Change (%) Date
Knoll Capital Management LP 3.20 5,881,879 +0.0 03/31/2026
Renaissance Technologies Corp 0.26 473,442 +338.4 03/31/2026
Parkman Healthcare Partners LLC 0.15 274,497 -4.9 06/30/2026
Seven Fleet Capital Management LP 0.11 205,542 +51.9 03/31/2026
Marshall Wace Asset Management Ltd 0.11 195,780 -68.8 03/31/2026
Northern Trust Corp 0.08 146,854 -1.2 03/31/2026
XTX Topco Ltd 0.07 131,622 +0.0 03/31/2026
Schonfeld Strategic Advisors LLC 0.03 55,223 -90.7 03/31/2026
Signature Estate & Investment Advisors 0.03 47,328 +0.0 06/30/2026

Funds

Funds ENTX
Name Stake (%) Shares Change (%) Date
WEALTHGATE Biotech Fund Inst 0.04 76,557 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?